AERI · Categories · Form 4

AERI - SEC Form 4 insider transactions

Aerie Pharmaceuticals Inc. (AERI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for AERI

• 1297d
  SEC Form 4: Mchugh Julie returned $245,449 worth of shares to the company (16,095 units at $15.25), closing all direct ownership in the company to cover taxes

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Mcgraw Benjamin F Iii returned $640,256 worth of shares to the company (41,984 units at $15.25), closing all direct ownership in the company to satisfy tax liability

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Mcdonnell Peter J returned $121,924 worth of shares to the company (7,995 units at $15.25), closing all direct ownership in the company (for withholding tax)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Kopczynski Casey C. returned $4,273,721 worth of shares to the company (280,244 units at $15.25), closing all direct ownership in the company (withholding tax)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Lang Peter Frederick returned $706,029 worth of shares to the company (46,297 units at $15.25), closing all direct ownership in the company (for withholding tax)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Larocca John returned $817,171 worth of shares to the company (53,585 units at $15.25), closing all direct ownership in the company to satisfy tax liability

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Gryska David W returned $205,738 worth of shares to the company (13,491 units at $15.25), closing all direct ownership in the company (tax liability)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Du Toit Michael returned $245,449 worth of shares to the company (16,095 units at $15.25), closing all direct ownership in the company to cover taxes

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Croarkin Richard returned $245,449 worth of shares to the company (16,095 units at $15.25), closing all direct ownership in the company (for withholding tax)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Calabrese Jeffrey returned $283,421 worth of shares to the company (18,585 units at $15.25), closing all direct ownership in the company (tax withholding)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1297d
  SEC Form 4: Kannan Raj returned $3,290,691 worth of shares to the company (215,783 units at $15.25), closing all direct ownership in the company to cover taxes

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1315d
  SEC Form 4: Calabrese Jeffrey covered exercise/tax liability with 179 shares, decreasing direct ownership by 0.95% to 18,585 units to satisfy tax liability

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1394d
  SEC Form 4: Larocca John covered exercise/tax liability with 771 shares, decreasing direct ownership by 1% to 53,585 units to satisfy withholding obligation

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1394d
  SEC Form 4: Calabrese Jeffrey covered exercise/tax liability with 265 shares, decreasing direct ownership by 1% to 18,764 units (withholding obligation)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1428d
  SEC Form 4: Calabrese Jeffrey covered exercise/tax liability with 266 shares, decreasing direct ownership by 1% to 19,029 units (tax liability)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1435d
  SEC Form 4: Calabrese Jeffrey was granted 11,276 shares, increasing direct ownership by 141% to 19,295 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1458d
  SEC Form 4: Mchugh Julie was granted 6,245 shares, increasing direct ownership by 63% to 16,095 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1458d
  SEC Form 4: Mcgraw Benjamin F Iii was granted 6,245 shares, increasing direct ownership by 17% to 41,984 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1458d
  SEC Form 4: Mcdonnell Peter J was granted 6,245 shares, increasing direct ownership by 357% to 7,995 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1458d
  SEC Form 4: Gryska David W was granted 6,245 shares, increasing direct ownership by 119% to 11,495 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1458d
  SEC Form 4: Du Toit Michael was granted 6,245 shares, increasing direct ownership by 63% to 16,095 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1458d
  SEC Form 4: Croarkin Richard was granted 6,245 shares, increasing direct ownership by 63% to 16,095 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1541d
  SEC Form 4: Kopczynski Casey C. was granted 19,015 shares, increasing direct ownership by 7% to 280,244 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1541d
  SEC Form 4: Larocca John was granted 19,015 shares, increasing direct ownership by 54% to 54,356 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1541d
  SEC Form 4 filed by Kannan Raj

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1541d
  SEC Form 4: Lang Peter Frederick was granted 46,297 shares

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1561d
  SEC Form 4: Mcgraw Benjamin F Iii covered exercise/tax liability with 10,324 shares, decreasing direct ownership by 22% to 35,739 units to satisfy withholding tax

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1568d
  SEC Form 4: Larocca John covered exercise/tax liability with 1,973 shares, decreasing direct ownership by 5% to 35,341 units to satisfy withholding obligation

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1582d
  SEC Form 4: Kopczynski Casey C. covered exercise/tax liability with 1,401 shares, decreasing direct ownership by 0.53% to 261,229 units to cover withholding tax

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1582d
  SEC Form 4: Larocca John covered exercise/tax liability with 768 shares, decreasing direct ownership by 2% to 37,314 units to satisfy withholding obligation

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1582d
  SEC Form 4: Mitro Thomas A covered exercise/tax liability with 2,421 shares, decreasing direct ownership by 3% to 81,418 units (tax withholding)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1583d
  SEC Form 4: Hollander David covered exercise/tax liability with 927 shares, decreasing direct ownership by 3% to 30,749 units (withholding obligation)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1583d
  SEC Form 4: Kopczynski Casey C. covered exercise/tax liability with 1,839 shares, decreasing direct ownership by 0.70% to 262,630 units to satisfy tax liability

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1583d
  SEC Form 4: Larocca John covered exercise/tax liability with 1,590 shares, decreasing direct ownership by 4% to 38,082 units (for tax liability)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1583d
  SEC Form 4: Mitro Thomas A covered exercise/tax liability with 2,870 shares, decreasing direct ownership by 3% to 83,839 units to satisfy withholding obligation

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1590d
  SEC Form 4: Mcginley Kathleen covered exercise/tax liability with 878 shares, decreasing direct ownership by 4% to 23,993 units (withholding tax)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1631d
  SEC Form 4: Kannan Raj was granted 215,783 shares

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1668d
  SEC Form 4: Hollander David covered exercise/tax liability with 2,162 shares, decreasing direct ownership by 6% to 31,676 units to cover taxes

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1722d
  SEC Form 4: Mcgraw Benjamin F Iii was granted 34,513 units of Common Stock, increasing direct ownership by 299% to 46,063 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1758d
  SEC Form 4: Staten Christopher covered exercise/tax liability with 877 units of Common Stock, decreasing direct ownership by 4% to 21,710 units (for tax liability)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1758d
  SEC Form 4: LaRocca John covered exercise/tax liability with 765 units of Common Stock, decreasing direct ownership by 2% to 39,672 units (for withholding tax)

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1815d
  SEC Form 4: GRYSKA DAVID W was granted 1,750 units of Common Stock, increasing direct ownership by 50% to 5,250 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1815d
  SEC Form 4: MCGRAW BENJAMIN F III was granted 1,750 units of Common Stock, increasing direct ownership by 18% to 11,550 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1815d
  SEC Form 4: McHugh Julie was granted 1,750 units of Common Stock, increasing direct ownership by 22% to 9,850 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1815d
  SEC Form 4: du Toit Michael was granted 1,750 units of Common Stock, increasing direct ownership by 22% to 9,850 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1815d
  SEC Form 4: Cagle Gerald D. was granted 1,750 units of Common Stock, increasing direct ownership by 10% to 20,050 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1815d
  SEC Form 4: McDonnell Peter J was granted 1,750 units of Common Stock

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1815d
  SEC Form 4: Croarkin Richard was granted 1,750 units of Common Stock, increasing direct ownership by 22% to 9,850 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1931d
  SEC Form 4: J Richard Rubino disposed of $6,421 worth of Common Stock (410 units at $15.66), decreasing ownership by 0.12% to 353,937 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1931d
  SEC Form 4: A Thomas Mitro disposed of $11,949 worth of Common Stock (763 units at $15.66), decreasing ownership by 0.87% to 86,709 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1931d
  SEC Form 4: C. Casey Kopczynski disposed of $5,136 worth of Common Stock (328 units at $15.66), decreasing ownership by 0.12% to 264,469 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1931d
  SEC Form 4: Jr Vicente Anido disposed of $26,622 worth of Common Stock (1,700 units at $15.66), decreasing ownership by 0.72% to 233,396 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1933d
  SEC Form 4: John Larocca disposed of $24,595 worth of Common Stock (1,542 units at $15.95), decreasing ownership by 4% to 40,437 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1939d
  SEC Form 4: C. Casey Kopczynski exercised 60,651 units of Common Stock at a strike of $0.20 and disposed of $11,897 worth of Common Stock (725 units at $16.41), increasing ownership by 29% to 264,797 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1947d
  SEC Form 4: Jr Vicente Anido disposed of $140,727 worth of Common Stock (7,954 units at $17.69), decreasing ownership by 3% to 235,096 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1947d
  SEC Form 4: C. Casey Kopczynski disposed of $39,683 worth of Common Stock (2,243 units at $17.69), decreasing ownership by 1% to 204,871 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1947d
  SEC Form 4: John Larocca disposed of $18,723 worth of Common Stock (1,059 units at $17.68), decreasing ownership by 2% to 41,979 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1947d
  SEC Form 4: A Thomas Mitro disposed of $66,379 worth of Common Stock (3,752 units at $17.69), decreasing ownership by 4% to 87,472 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1947d
  SEC Form 4: J Richard Rubino disposed of $56,277 worth of Common Stock (3,181 units at $17.69), decreasing ownership by 0.89% to 354,347 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)
• 1948d
  SEC Form 4: David Hollander was granted 11,000 units of Common Stock, increasing ownership by 48% to 33,838 units

  4 - AERIE PHARMACEUTICALS INC (0001337553) (Issuer)

Other AERI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends